Luxfer Holdings PLC
NYSE:LXFRIndustrial - Machinery
+$0.51 today
- Market cap
- $464.28M
- Beta
- 1.12
- P/E (TTM)
- 86.4
- EPS (TTM)
- $0.22
- Dividend yield
- 2.76%
Volume 0.58M
Average 0.18M
LXFR Other Working Capital
Cash effect of changes in other operating assets and liabilities.
Luxfer Holdings PLCNYSE: LXFR
Other Working Capital · Q1 FY2026 · quarter ended Mar 2026
Other working capital growth accelerates
Q1 FY2026 other working capital of $4.4M rose 300.0% year over year, ahead of the -63.8% change in trailing-twelve-month other working capital. Over 3 fiscal years it compounded at -64.3% a year.
Context
- Other working capital amounted to 0.2% of revenue in FY2025, down 3.0 pp from a year earlier.
- Other working capital increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +300.0% holds above the trailing-twelve-month pace of -63.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Working Capital history
USD · from the cash flow
- Latest · FY2025
- (800K) USD
- Year-over-year change
- -106.4%
| Period | Period end | Other Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (800K) | -106.4% |
| FY2024 | 2024-12-31 | 12.5M | +156.3% |
| FY2023 | 2023-12-31 | (22.2M) | -26.1% |
| FY2022 | 2022-12-31 | (17.6M) | -240.8% |
| FY2021 | 2021-12-31 | 12.5M | — |
Other Working Capital vs competitors
How LXFR compares with its peers on the latest reported figures
- LXFR's LTM Mar 2026 other working capital of $2.49M is the 9th largest of the 11 companies compared; the peer median is $3.41M.
- Its year-over-year change of -63.8% is the 7th highest of 11, against a peer median of +48.4%.
- Other working capital amounts to 0.7% of revenue for LXFR, versus a peer median of 1.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $72.39M | +141.4% | — | 4.9% | |
| LTM Mar 2026 | $46.89M | +212.7% | +60.6% | 7.0% | |
| LTM Mar 2026 | $42.4M | -10.5% | -1.3% | 2.7% | |
| LTM Mar 2026 | $8.6M | -208.9% | +6.0% | 1.3% | |
| LTM Mar 2026 | $6.5M | -64.5% | -16.8% | 0.4% | |
| LTM Mar 2026 | $5.54M | -156.1% | — | — | |
| LTM Mar 2026 | $3.76M | +145.5% | — | 1.0% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $3.14M | +107.3% | +239.2% | 1.9% |
| LTM Mar 2026 | $2.49M | -63.8% | -64.3% | 0.7% | |
| LTM Mar 2026 | $1.28M | -504.4% | -42.2% | 1.3% | |
| LTM Mar 2026 | $1.24M | +127.4% | -39.0% | 0.3% | |
| Peer median (excluding LXFR) | $3.41M | +48.4% | -1.3% | 1.3% | |
Competitors are the stored peer set for LXFR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 30M | 32M | (2.6M) | 18.3M | 7.7M |
| Depreciation & Amortization | 15.6M | 18M | 12.7M | 13.4M | 9.9M |
| Deferred Income Tax | (1.6M) | 8.7M | (600K) | 1.1M | 6.2M |
| Stock-Based Compensation | 2.8M | 2.5M | 2.8M | 3.5M | 3.6M |
| Change in Working Capital | (1.2M) | (46.6M) | (8M) | 8.9M | (8.9M) |
| Accounts Receivables | (9.8M) | (25.3M) | 16.6M | (4.3M) | 4.3M |
| Inventory | (15.3M) | (25M) | 16.6M | (4.1M) | (6.7M) |
| Accounts Payables | 11.4M | 21.3M | (19M) | 4.8M | (5.7M) |
| Other Working Capital | 12.5M | (17.6M) | (22.2M) | 12.5M | (800K) |
| Other Non-Cash Items | (19.5M) | 1.3M | 22M | 5.9M | 15.5M |
| Operating Cash Flow | 26.1M | 15.9M | 26.3M | 51.1M | 34M |
| Capital Expenditures | (9.1M) | (8.3M) | (9.4M) | (10.3M) | (7.8M) |
| Acquisitions (Net) | 4.1M | (1M) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (100K) | 3.6M | (100K) | 7.3M | 2.7M |
| Investing Cash Flow | (5.1M) | (5.7M) | (9.5M) | (3.4M) | (5.1M) |
| Debt Repayment | 6.4M | 24.8M | (10.2M) | (27.2M) | (7.2M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (6.4M) | (11.1M) | (2.7M) | (2.3M) | (3.1M) |
| Dividends Paid | (13.6M) | (14.2M) | (14M) | (14M) | (13.9M) |
| Other Financing Activities | (2.5M) | (1.4M) | (600K) | (500K) | (800K) |
| Financing Cash Flow | (16.1M) | (2M) | (27.5M) | (44M) | (25M) |
| Effect of Forex Changes | 0 | (1.7M) | 400K | 0 | 500K |
| Net Change in Cash | 4.9M | 6.5M | (10.3M) | 3.7M | 4.4M |
| Free Cash Flow | 17M | 7.6M | 16.9M | 40.8M | 26.2M |
Luxfer Holdings PLC
NYSE:LXFR
Intrinsic Alpha fair value
Locked
Current Price
$17.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.